Human Reproduction
Journal Title
- Human Reproduction
ISSN
- E 1460-2350 | P 0268-1161 | 1460-2350 | 0268-1161
Publisher
- Oxford University Press
- OUP
Listed on(Coverage)
| JCR | 1997-2019 |
|---|---|
| SJR | 1999-2019 |
| CiteScore | 2011-2019 |
| SCI | 2010-2019 |
| SCIE | 2010-2021 |
| CC | 2016-2021 |
| SCOPUS | 2017-2020 |
| MEDLINE | 2016-2021 |
| EMBASE | 2016-2020 |
Active
- Active
based on the information
- SCOPUS:2020-10
Country
- ENGLAND
Aime & Scopes
- Human Reproduction publishes full length, peer reviewed papers reporting original research, including randomized controlled trials, as well as meta-analyses, opinions, debates, invited editorials and editorial commentaries and concise clinical case reports of outstanding originality and importance. Mini-reviews forming part of the ‘ Developments in Reproductive Biology and Medicine ’ series are also occasionally published. These articles aim to summarize concisely particularly important and rapidly developing areas of reproductive medicine for which not enough has been published to enable more substantive reviews to be written. The majority of ‘Developments’ reviews will originate from the journal’s Associate Editors but uninvited contributions are also welcomed. The scope of Human Reproduction covers the clinical science and medical aspects of reproduction, including: reproductive tract physiology and pathology, gonad function and gametogenesis, fertilization, embryo development, implantation and early pregnancy. Studies in the following areas will be considered: andrology, contraception, early pregnancy (first trimester), embryo development, ethical and legal issues, fertilisation, fertility preservation, gametogenesis, gonadal function, implantation, infectious disease, infertility, menstrual disorders, psycho-social issues, reproductive genetics, reproductive surgery, reproductive oncology, reproductive epidemiology, and stem cell research. Research that would be classified as clearly in the fields of obstetrics (here defined as being beyond the first trimester of pregnancy) or gynaecological oncology will not normally be published. Studies using animal models or in vitro cellular models of reproductive health and disease will only be considered if they demonstrate direct relevance to human reproduction. Animal and cellular studies with only indirect relevance to human reproduction are more appropriate for consideration in MHR .